Guidelines for the diagnosis and management of osteoporosis in Poland. Update 2022.

diagnosis fracture risk osteoporosis treatment

Journal

Endokrynologia Polska
ISSN: 2299-8306
Titre abrégé: Endokrynol Pol
Pays: Poland
ID NLM: 0370674

Informations de publication

Date de publication:
2023
Historique:
received: 13 12 2022
accepted: 14 12 2022
entrez: 27 2 2023
pubmed: 28 2 2023
medline: 3 3 2023
Statut: ppublish

Résumé

Guidelines to provide an update of the previously published Polish recommendations for the management of women and men with osteoporosis have been developed in line with advances in medical knowledge, evidence-based data, and new concepts in diagnostic and therapeutic strategies. A Working Group of experts from the Multidisciplinary Osteoporosis Forum and from the National Institute of Geriatrics, Rheumatology, and Rehabilitation in Warsaw performed a thorough comprehensive review of current relevant publications in the field (including all age groups of people and management of secondary osteoporosis), and they evaluated epidemiological data on osteoporosis in Poland and the existing standards of care and costs. A voting panel of all co-authors assessed and discussed the quality of evidence to formulate 29 specific recommendations and voted independently the strength of each recommendation. This updated practice guidance highlights a new algorithm of the diagnostic and therapeutic procedures for individuals at high and very high fracture risk and presents a spectrum of general management and the use of medication including anabolic therapy. Furthermore, the paper discusses the strategy of primary and secondary fracture prevention, detection of fragility fractures in the population, and points to vital elements for improving management of osteoporosis in Poland.

Identifiants

pubmed: 36847720
pii: VM/OJS/J/93160
doi: 10.5603/EP.a2023.0012
doi:

Types de publication

Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

5-15

Auteurs

Piotr Głuszko (P)

Department of Rheumatology, National Institute of Geriatrics, Rheumatology, and Rehabilitation, Warsaw, Poland. zruj@mp.pl.

Ewa Sewerynek (E)

Department of Endocrine Disorders and Bone Metabolism, Medical University of Lodz, Poland.

Waldemar Misiorowski (W)

Centre of Postgraduate Medical Education, Bielanski Hospital, Warsaw, Poland.

Jerzy Konstantynowicz (J)

Department of Paediatrics, Rheumatology, Immunology, and Metabolic Bone Diseases, Medical University of Bialystok, Poland.

Ewa Marcinowska-Suchowierska (E)

Department of Geriatrics and Gerontology, School of Public Health, Medical Centre of Postgraduate Education, Warsaw, Poland.

Tomasz Blicharski (T)

Department of Orthopaedics and Rehabilitation, Medical University of Lublin, Lublin, Poland.

Mirosław Jabłoński (M)

Laboratory of Locomotor Systems Research, Department of Rehabilitation and Physiotherapy, Medical University of Lublin, Poland.

Edward Franek (E)

Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland.

Tomasz Kostka (T)

Department of Geriatrics Healthy Ageing Research Centre (HARC) Medical University of Lodz, Poland.

Maciej Jaworski (M)

Department of Biochemistry, Radioimmunology and Experimental Medicine, The Children's Memorial Health Institute, Warsaw, Poland.

Elżbieta Karczmarewicz (E)

Multidisciplinary Osteoporosis Forum, Warsaw, Poland, Poland.

Ewa Kalinka (E)

Department of Oncology Polish Mother's Memorial Hospital - Research Institute, Lodz, Poland.

Krystyna Księżopolska-Orłowska (K)

Committee for Rehabilitation, Physical Culture and Social Integration of the Polish Academy of Sciences, Krupia Wl., Poland.

Andrzej Więcek (A)

Department of Nephrology, Transplantation, and Internal Medicine, Medical University of Silesia, Katowice, Poland.

Roman S Lorenc (RS)

Multidisciplinary Osteoporosis Forum, Warsaw, Poland, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH